1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow CV Technologies: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adults CVT-E002 (Cold-FX); a natural health product - Upper Respiratory Infection | Phase 3 | Completed | CV Technologies | 500 | 2005-12-01 | 2009-06-08 |
Common Cold (1) · Influenza, Human (1) · Respiratory Tract Infections (1)
COLD-fX (1)
Canada (1)
Gerry Predy, MD (1)